Special clinical interests in breast & lower gastrointestinal and anal malignancies
Dr Charles Wilson trained in London at the Hammersmith and the Royal Marsden Hospitals before joining Addenbrookes Hospital as a Consultant Clinical Oncologist in 1993 with special interest in Breast and GI Malignancies.
As Clinical Director of Oncology in 2000-2005, he oversaw the development of the first NHS Tomotherapy unit. He was also closely involved with the Wallace Centre in Cambridge which opened in 2004. (In June 2010 Wallace Cancer Care received the Queen’s Award for Voluntary Service for the excellence of the voluntary work done with cancer patients and their families.) He was the Director of the Cambridge Breast Unit (2010 -2014), and Co-Chair of the Anglia Network Breast Site Specific Group and clinical lead for anal cancer for the Anglia Network.
Dr Wilson was a member of National Chemotherapy Advisory Group that produced NCAG report in 2009 advising the Department of Health of the developments needed for high quality chemotherapy services.
He was Chair of the Chemotherapy Clinical Information Group (2010-2015) that oversaw the development of Systemic Anti-Cancer Therapy (SACT) dataset. This now provides essential guidance to the DOH, commissioners and providers for the delivery of chemotherapy in the UK.
Dr Wilson’s research interests have included the development and implementation of new radiotherapy techniques in breast and anal malignancies and he has been the local principal investigator for several NCRN trials in breast and colorectal systemic therapy.
- Royal College of Radiologists
- Royal College of Physicians